Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway

被引:0
|
作者
Rock, KL [1 ]
Clark, K [1 ]
机构
[1] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 156卷 / 10期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By conjugation of proteins to beads, Ags can be selectively targeted into the MHC class I pathway of phagocytes in vivo and can stimulate CTL responses. Because phagocytes also present particulate Ag on MHC class II molecules, we examined whether these Ags stimulated concomitant CD4 T cell immunity. Although the priming of CD4 T cells with soluble OVA required adjuvants, particulate Ag was stimulatory when injected in saline. We next examined whether CD4 T tell responses played a role in the generation of CTL to particulate Ag. At low concentrations of Ag, OVA primed CTLs in wild-type mice but not in MHC class II-deficient animals, indicating that MHC class II presentation of Ag was essential for CTL generation. These data both support a model where CD4 T cells collaborate with CTLs as part of a three-cell interaction and identify a phagocyte as the third cell in this reaction. Interestingly, injection of higher concentrations of the same Ag primed equivalent CTL responses in both wild-type and MHC class II-deficient mice. These results indicate that a key variable in determining whether CTL generation is helper cell dependent or independent is the dose of immunogen. This may explain in part why CTL responses to abundant Ags, such as viruses, tend to be helper independent, while responses to less abundant Ags, such as minor histocompatibility Ags, require T helper cells. In addition, these results also point to the potential of using particulate Ags to prime or boost responses in settings with CD4 immunodeficiency.
引用
收藏
页码:3721 / 3726
页数:6
相关论文
共 50 条
  • [21] MHC class II restricted antigen presentation
    Pieters, J
    CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 89 - 96
  • [22] Diversity in MHC class II antigen presentation
    Robinson, JH
    Delvig, AA
    IMMUNOLOGY, 2002, 105 (03) : 252 - 262
  • [23] ANTIGEN PRESENTATION PATHWAYS TO CLASS-I AND CLASS-II MHC-RESTRICTED LYMPHOCYTES-T
    BRACIALE, TJ
    MORRISON, LA
    SWEETSER, MT
    SAMBROOK, J
    GETHING, MJ
    BRACIALE, VL
    IMMUNOLOGICAL REVIEWS, 1987, 98 : 95 - 114
  • [24] MHC class I antigen presentation by megakaryocytes
    Zufferey, A.
    Speck, E. R.
    Guo, L.
    Aslam, R.
    Kapur, R.
    Semple, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 617 - 617
  • [25] Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo
    SchutzeRedelmeier, MP
    Gournier, H
    GarciaPons, F
    Moussa, M
    Joliot, AH
    Volovitch, M
    Prochiantz, A
    Lemonnier, FA
    JOURNAL OF IMMUNOLOGY, 1996, 157 (02): : 650 - 655
  • [26] Role of tapasin in MHC class I antigen presentation in vivo
    Garbi, N
    Tan, P
    Momburg, F
    Hämmerling, GJ
    PROGRESS IN BASIC AND CLINICAL IMMUNOLOGY, 2001, 495 : 71 - 78
  • [27] Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes
    Costantino, Cristina Maria
    Spooner, Eric
    Ploegh, Hidde L.
    Hafler, David A.
    PLOS ONE, 2012, 7 (01):
  • [28] Generation of MHC class I and MHC class II reporter mice for investigation of antigen presentation by oligodendroglia
    Harrington, E.
    Heo, D.
    Lu, T. -Y.
    Calabresi, P.
    Bergles, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 38 - 39
  • [29] Loading of MHC class I and II presentation pathways by exogenous antigens: A quantitative in vivo comparison
    Storni, T
    Bachmann, MF
    JOURNAL OF IMMUNOLOGY, 2004, 172 (10): : 6129 - 6135
  • [30] Sulforaphane Enhances MHC Class II-Restricted Presentation of Exogenous Antigens
    Shin, Seulmee
    Jung, Ki-Sung
    Park, Yoonhee
    Ko, Young-Wook
    Lee, Chong-Kil
    Cho, Kyunghae
    Ha, Nam-Joo
    Kim, Kyungjae
    BIOMOLECULES & THERAPEUTICS, 2011, 19 (01) : 77 - 83